Risk of second malignant neoplasms after childhood central nervous system malignant tumours: An international study

European Journal of Cancer

Volumn 44, Issue 6, 2008, Pages 830-839

  Maule, M ^a   Scelo G ^b   Pastore, G ^a,c   Brennan, P ^b   Hemminki, K ^d,e   Pukkala, E ^f   Weiderpass, E ^g,h   Olsen, J H ⁱ   Tracey, E ^j   McBride, M L ^k   Brewster, D H ^l   Pompe Kirn, V ^m   Tonita, J M ⁿ   Kliewer, E V ^o,p   Chia, K S ^q,r   Jonasson, J G ^s,t   Martos, C ^u   Magnani, C ^a,c   Boffetta, P ^b  

^a Cancer Epidemiology Unit   (Italy)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e KAROLINSKA INSTITUTE   (Sweden)

^f FINNISH CANCER REGISTRY   (Finland)

^g CANCER REGISTRY OF NORWAY   (Norway)

^h FOLKHÄLSAN RESEARCH CENTER   (Finland)

ⁱ INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^j New South Wales Cancer Registry   (Australia)

^k BRITISH COLUMBIA CANCER AGENCY   (Canada)

^l INFORMATION SERVICES DIVISION   (United Kingdom)

^m INSTITUTE OF ONCOLOGY   (Slovenia)

ⁿ SASKATCHEWAN CANCER AGENCY   (Canada)

^o Epidemiology and Cancer Registry   (Canada)

^p UNIVERSITY OF MANITOBA   (Canada)

^q Centre for Molecular Epidemiology   (Singapore)

^r Singapore Cancer Registry ^*  (Singapore)

^s ICELANDIC CANCER REGISTRY   (Iceland)

^t UNIVERSITY OF ICELAND   (Iceland)

^u Cancer Registry of Zaragoza   (Spain)

more..

Author keywords

Childhood cancer; Neoplasms; Primary central nervous system neoplasms; Second primary

Indexed keywords

ADOLESCENT; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND CANCER; SURVIVAL RATE; SURVIVAL TIME; SURVIVOR; THYROID CANCER;

ADOLESCENT; ADULT; AGED; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RISK;

EID: 41949134625     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.02.012     Document Type: Article

References (45)

1. Khatua S., and Jalali R. Recent advances in the treatment of childhood brain tumors. Pediatr Hematol Oncol 22 (2005) 361-371
2. Peris-Bonet R., Martinez-Garcia C., Lacour B., et al. Childhood central nervous system tumours - incidence and survival in Europe (1978-1997): report from Automated Childhood Cancer Information System project. Eur J Cancer 42 (2006) 2064-2080
3. Ries L.A.G., Melbert D., Krapcho M., et al. SEER cancer statistics review, 1975-2004 (2007), National Cancer Institute, Bethesda (MD)
4. Steliarova-Foucher E., Stiller C., Kaatsch P., et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet 364 (2004) 2097-2105
5. Mulhern R.K., and Butler R.W. Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehabil 7 (2004) 1-14 [discussion 15-6]
6. Packer R.J. Progress and challenges in childhood brain tumors. J Neurooncol 75 (2005) 239-242
7. Devarahally S.R., Severson R.K., Chuba P., Thomas R., Bhambhani K., and Hamre M.R. Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence. Pediatr Hematol Oncol 20 (2003) 617-625
8. Goldstein A.M., Yuen J., and Tucker M.A. Second cancers after medulloblastoma: population-based results from the United States and Sweden. Cancer Causes Control 8 (1997) 865-871
9. Inskip P.D. Multiple primary tumors involving cancer of the brain and central nervous system as the first or subsequent cancer. Cancer 98 (2003) 562-570
10. Little M.P., de Vathaire F., Shamsaldin A., et al. Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer 78 (1998) 269-275
11. Neglia J.P., Robison L.L., Stovall M., et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98 (2006) 1528-1537
12. Inskip P.D., and Curtis R.E. New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer 121 (2007) 2233-2240
13. IARC. Cancer incidence in five continents vol. VIII (2002), IARC Sci. Publ. 1-781
14. Olsen J.H., Garwicz S., Hertz H., et al. Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. BMJ 307 (1993) 1030-1036
15. Slee V.N. The International Classification of Diseases: ninth revision (ICD-9). Ann Intern Med 88 (1978) 424-426
16. Percy C., Van Holten V., and Muir C. International classification of diseases for oncology (1990), World Health Organization, Geneva
17. Muir C.S., and Percy C. Classification and coding for neoplasms. In: Jensen O.M., Parkin D.M., MacLennan R., Muir C.S., and Skeet R.G. (Eds). Cancer registration - principles and methods vol. I (1991), IARC Scientific Publication No. 95, IARC, Lyon
18. Breslow N.E., and Day N.E. Statistical methods in cancer research. The design and analysis of cohort studies vol. II (1987), IARC Sci. Publ. p. 65-72
19. Breslow N.E., and Day N.E. Statistical methods in cancer research. The design and analysis of cohort studies vol. II (1987), IARC Sci Publ. p. 96-8
20. Gooley T.A., Leisenring W., Crowley J., and Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999) 695-706
21. Woodward M. Epidemiology - study design and data analysis (1999), Chapman & Hall, Boca Raton
22. World Health Organization. Regional Office for Europe. European mortality database (MDB); 2007.
23. Travis L.B. The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 15 (2006) 2020-2026
24. Kony S.J., de Vathaire F., Chompret A., et al. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 350 (1997) 91-95
25. Magnani C., Pastore G., Coebergh J.W., Viscomi S., Spix C., and Steliarova-Foucher E. Trends in survival after childhood cancer in Europe, 1978-1997: report from the Automated Childhood Cancer Information System project (ACCIS). Eur J Cancer 42 (2006) 1981-2005
26. Gatta G., Capocaccia R., Coleman M.P., Ries L.A., and Berrino F. Childhood cancer survival in Europe and the United States. Cancer 95 (2002) 1767-1772
27. Pizzo P.A., and Poplack D.G. Principles and practice of pediatric oncology (2006), Lippincott Williams & Wilkins, Philadelphia
28. Hawkins M.M., Draper G.J., and Kingston J.E. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 56 (1987) 339-347
29. Boice J.D., Land C.E., and Preston D.L. Ionizing radiation. In: Schottenfeld D.F.J. (Ed). Cancer epidemiology and prevention (1996), Oxford Press, New York
30. Sigurdson A.J., Ronckers C.M., Mertens A.C., et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet 365 (2005) 2014-2023
31. Peterson K.M., Shao C., McCarter R., MacDonald T.J., and Byrne J. An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors. Pediatr Blood Cancer 47 (2006) 83-88
32. IARC. Ionizing radiation, part 1: X- and gamma-radiation, and neutrons. Overall introduction. IARC Monogr Eval Carcinog Risks Hum 75 Pt 1 (2000) 35-115
33. Narod S.A., Stiller C., and Lenoir G.M. An estimate of the heritable fraction of childhood cancer. Br J Cancer 63 (1991) 993-999
34. Narod S.A., Hawkins M.M., Robertson C.M., and Stiller C.A. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet 60 (1997) 474-485
35. Bader J.L., and Miller R.W. Neurofibromatosis and childhood leukemia. J Pediatr 92 (1978) 925-929
36. MacArthur A.C., Spinelli J.J., Rogers P.C., Goddard K.J., Phillips N., and McBride M.L. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada. Pediatr Blood Cancer 48 (2007) 453-459
37. Cardous-Ubbink M.C., Heinen R.C., Bakker P.J., et al. Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer 43 (2007) 351-362
38. Bassal M., Mertens A.C., Taylor L., et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 24 (2006) 476-483
39. Hammal D.M., Bell C.L., Craft A.W., and Parker L. Second primary tumors in children and young adults in the North of England (1968-99). Pediatr Blood Cancer 45 (2005) 155-161
40. Jazbec J., Ecimovic P., and Jereb B. Second neoplasms after treatment of childhood cancer in Slovenia. Pediatr Blood Cancer 42 (2004) 574-581
41. Jenkinson H.C., Hawkins M.M., Stiller C.A., Winter D.L., Marsden H.B., and Stevens M.C. Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer 91 (2004) 1905-1910
42. Klein G., Michaelis J., Spix C., et al. Second malignant neoplasms after treatment of childhood cancer. Eur J Cancer 39 (2003) 808-817
43. Neglia J.P., Friedman D.L., Yasui Y., et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 93 (2001) 618-629
44. Garwicz S., Anderson H., Olsen J.H., et al. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer 88 (2000) 672-678
45. Westermeier T., Kaatsch P., Schoetzau A., and Michaelis J. Multiple primary neoplasms in childhood: data from the German Children's Cancer Registry. Eur J Cancer 34 (1998) 687-693